News summarySOPHiA GENETICS Investor RelationsNov 3, 2026, 12:00 PM
Q3 2026 results: revenue grew 25%; full-year revenue outlook maintained at upper end
earningscorporate_earnings
On Nov. 3, SOPHiA GENETICS reported Q3 revenue of $24.3 million, up 25% year over year; net loss was $20.3 million, up 1%, and adjusted EBITDA loss was $6.1 million, improving 31%. It expected FY 2026 revenue at the upper end of $94–$96 million guidance and adjusted EBITDA loss of $29–$32 million.